The X region of the HTLV-I genome contains four major open reading frames (ORFs), two of which, termed x-I and x-II, are of still unde®ned biological signi®cance. By indirect immuno¯uorescence and dual labeling with marker proteins, we demonstrate that p13 II , an 87-amino acid protein coded by the x-II ORF, is selectively targeted to mitochondria. Mutational analysis revealed that mitochondrial targeting of p13 II is directed by an atypical 10-amino acid signal sequence that is not cleaved upon import and is able to target the Green Fluorescent Protein to mitochondria. Expression of p13 II results in speci®c alterations of mitochondrial morphology and distribution from a typical string-like, dispersed network to round-shaped clusters, suggesting that p13 II might interfere with processes relying on an intact mitochondrial architecture. Functional studies of mitochondria with the cationic¯uorochrome tetramethylrhodamine revealed that a subpopulation of the cells with p13 II -positive mitochondria show a disruption in the mitochondrial inner membrane potential (Dc), an early event observed in cells committed to apoptosis. Taken together, these results suggest novel virus-cell interactions that might be important in HTLV-I replication and/or pathogenicity.
Introduction
As the causative agent of adult T-cell leukemia (ATL), an aggressive malignancy of mature CD4+ T-cells, HTLV-I is the only retrovirus known to be oncogenic in humans; the virus also causes a demyelinizing neurological syndrome termed tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) (reviewed by Cann and Chen, 1996) . HTLV-I possesses a complex genome whose expression is controlled by the viral regulatory proteins Rex and Tax, encoded in the X region of the viral genome (reviewed by Rabson and Graves, 1997) . The X region spans about 1.6 kb and contains four major open reading frames (ORFs) designated x-I, x-II, x-III and x-IV.
Rex and Tax, encoded in the x-III and x-IV ORFs, respectively, are produced from a dicistronic doubly spiced mRNA containing exons 1, 2 and 3. Tax is a nuclear protein that stimulates transcription from the viral LTR promoter and modulates expression of several cellular genes (reviewed by Yoshida, 1996) . Numerous studies have established that Tax is essential, although not sucient, for HTLV-Imediated transformation of human T lymphocytes (reviewed by Franchini, 1995) . However, several aspects of HTLV-I pathogenesis remain poorly understood, such as the mechanism underlying the long latency period between primary infection and disease, and the factors determining whether infection will be either clinically inconsequential or lead to development of ATL or TSP/HAM.
Searching for viral determinants of HTLV-I pathogenesis, recent studies have examined the functional signi®cance of other X region products. Additional alternatively spliced mRNAs encoding ORFs x-I, x-II and x-III proteins are detected in HTLV-I-infected cells Ciminale et al., 1992; Koralnik et al., 1992) . A singly spliced mRNA containing exons 1 and A codes for p12 I , a 99-amino acid x-I ORF protein (Koralnik et al., 1992) that displays oncogenic potential in vitro , binds to the b and g c chains of the IL-2 receptor (Mulloy et al., 1996) , and is necessary for persistent infection in a rabbit animal model (Collins et al., 1998) .
Products of the x-II ORF are encoded in two alternatively spliced mRNAs (Figure 1) . A doubly spliced mRNA containing exons 1, 2 and B codes for Tof/p30 II , a 30-kDa nucleolar/nuclear protein (Ciminale et al., 1992; Koralnik et al., 1992) ; a singly spliced mRNA containing exons 1 and C encodes p13 II , a 13-kDa protein corresponding to the 87 carboxy-terminal amino acids of Tof/p30 II (Koralnik et al., 1992) .
The present study was aimed at ®nding clues to the functional signi®cance of p13 II .
Results of immunouorescence assays demonstrated that p13
II is selectively targeted to mitochondria; mutational analysis led to the identi®cation of the sequence requirements determining this targeting property. Interestingly, p13 II expression results in speci®c alterations in mitochondrial morphology and architecture and disrupts the mitochondrial inner membrane potential in a subpopulation of cells, suggesting that this protein could be of functional relevance to HTLV-I replication and/or pathogenicity.
Results

Mitochondrial localization of p13 II
In a previous study of x-II ORF-encoded proteins, we observed that p13 II accumulated in punctate cytoplasmic structures, as well as in the nuclear matrix of a minority of the transfected cells (D'Agostino et al., 1997) . Surmising that the cytoplasmic structures might represent mitochondria, we compared the intracellular distribution of p13 II expressed by transient transfection to that of an endogenously expressed mitochondrial marker, the multienzyme complex III of the respiratory chain. To this end, the HeLa-derived cell line HLtat  was transfected with pCMV-p13   II   -HA1, which expresses p13 II modi®ed by the addition of the HA1 epitope at its carboxy terminus. The cells were analysed by indirect immuno¯uorescence using a mixture of rabbit anti-complex III serum and mouse anti-HA1 monoclonal antibody, followed by a mixture of Texas Red-conjugated anti-rabbit antibody to detect complex III and FITC-conjugated anti-mouse antibody to detect p13 . HLtat cells were transfected with the p13 II expression plasmid pCMV-p13 II -HA1. One day later, the cells were ®xed with formaldehyde, permeabilized using Nonidet P40, and analysed by indirect immuno¯uorescence using mouse anti-HA1 monoclonal antibody and FITC-conjugated anti-mouse antibody to visualize p13 II ; rabbit anti-complex III serum and Texas red-conjugated anti-rabbit antibody were used to detect complex III. Images were obtained using an excitation band of 540 ± 550 nm (left panel) and 450 ± 490 nm (middle panel); the image in the right panel is a doubleexposure photograph p13 II , a mitochondrial protein coded by HTLV-I V Ciminale et al drial membranes (reviewed by Neupert, 1997) . Recognition of the mitochondrial carrier system depends on the presence of`mitochondrial targeting signal' (MTS) sequences. Most of the MTS described thus far are located at the amino terminus of the protein, have a positive net charge (e.g., are rich in arginines), and are predicted to fold into an amphipathic a-helical conformation (reviewed by Neupert, 1997) .
To search for possible candidate sequences responsible for the mitochondrial targeting of p13 II , we analysed the protein's sequence with structure prediction programs ( Figure 3A) . These analyses showed that the amino terminal portion of the protein contains a short hydrophobic leader sequence (amino acids 1 ± 5) followed by two regions (amino acids 5 ± 14 and 19 ± 35, according to the Eisenberg method; Figure 3A3 ) that are predicted to fold into amphipathic a-helical structures. The latter region is also predicted to contain an a-helical core ( Figure 3A1 , amino acids 22 ± 30) according to the EMBL Pro®le Neural Network method (Rost and Sander, 1994) .
Based on this information, we searched for the MTS of p13
II by constructing a series of nested aminoterminal deletion mutants. The targeting properties of each mutant were tested in the context of Aequorea victoria Green¯uorescent protein (GFP), a protein that lacks speci®c intracellular targeting signals. Figure 3B ± E shows¯uorescence images of living HLtat cells transfected with vectors expressing unmodi®ed GFP or GFP fused either to the entire p13 II sequence or to deletion mutants. As shown in Figure 3B , unfused GFP was distributed throughout the cell in a diuse pattern. In contrast, p13 II -GFP was detected primarily in the mitochondria ( Figure 3C) Figure 3D ). In contrast, p13 II -M4-GFP, which initiated at amino acid 19 of p13 II , was eciently targeted to mitochondria ( Figure 3E ). Taken together, these results indicated that the sequence between amino acids 19 and 32, comprising the second putative amphipathic a-helical region of the protein, was necessary for mitochondrial targeting of p13 II and thus constituted at least a portion of the MTS.
Upon import into the mitochondria, MTS are commonly removed by proteolytic cleavage. Based on the position of its MTS, this cleavage process would reduce the size of p13 II by over one-third (at least 32 amino acids out of 87). To determine whether the targeting signal of p13 II is in fact cleaved, the electrophoretic mobility of p13 II produced in transfected HLtat cells was compared with that of p13 II produced in bacteria (see Materials and methods). Results of SDS ± PAGE and Western blot analysis ( Figure 3F) showed that, instead of migrating faster, as would be expected of a cleavage product, p13 produced in E. coli as described in Materials and methods. The blot was incubated with rabbit anti-Tof serum followed by horseradish peroxidase-conjugated anti-rabbit antibody (Amersham), developed using a chemiluminescence system (ECL, Amersham, or Supersignal, Pierce) and exposed to Hyper®lm MP (Amersham) The left-hand side of Figure 4A shows a DNA Stargenerated helical wheel model of the segment of p13 II between proline 19 and proline 33, which includes the region mapped with mutants M4 and M3. In this type of spatial representation, an amphipathic a helix would exhibit a partition of polar and hydrophobic residues on opposite sides of the helical structure. As shown in the right-hand portion of Figure 4A , the L21 ± R29 segment of this sequence displays a clear separation of hydrophobic and charged residues on the two sides of the helix, suggesting that it might represent the structural core of the p13 II MTS. The function of canonical amphipathic a-helical MTS depends on the presence of positively charged amino acids. As shown in Figure 4B , mutant p13 II DR-GFP, in which arginine residues located at positions 22, 25, 29 and 30 were substituted with glycines, was eciently targeted to mitochondria; likewise, substitution of arginines 9, 17, 22 and 25 with alanines did not change the targeting properties of the protein (data not shown). Taken together, these data suggest that, in contrast to canonical MTS, mitochondrial targeting of p13 II does not depend on the presence of basic residues within its MTS.
The p13 II MTS was examined in further detail by constructing GFP fusion proteins containing a smaller segment of p13 II at their amino terminus. Fusion of GFP to amino acids 22 ± 31 resulted in the hybrid protein MTS-GFP. As shown in Figure 4C , this GFP chimera was eciently targeted to mitochondria, demonstrating that amino acids 22 ± 31 functioned as a mitochondrial targeting signal in the absence of other portions of the protein. Although the MTS sequence of the HTLV-I variants CS and LAF dier at amino acids 28 (i.e., A in CS, T in LAF), the two signals were equally eective in targeting GFP to mitochondria (data not shown).
We next introduced substitutions of hydrophobic residues within the MTS sequence with polar and negatively charged residues that are not predicted to fold into an a-helical structure. As shown in Figure  4D , the resulting mutant, MTS-Da-GFP, was completely defective in mitochondrial targeting. These data suggest that the MTS of p13 II does not tolerate the presence of negatively charged or polar residues and might depend on the ability to form an a-helical, but not necessarily amphipathic, structure.
Eects of p13
II expression on mitochondrial morphology and distribution
Comparison of the images shown in Figure 2 revealed that p13 II -expressing mitochondria exhibited a markedly altered morphology compared to the typical ®lamentous shape of normal mitochondria found in the non-transfected cells. To assess the speci®city of this eect, we examined the morphology of mitochondria in cells transiently transfected with both a p13 II -expressing plasmid and a plasmid coding for the synthetic mitochondrial protein MT-GFP-HA1, consisting of the amino-terminal 31 amino acids of cytochrome c oxidase subunit VIII fused to GFP and the HA1 tag epitope (Rizzuto et al., 1995) . Results of dual labeling-indirect immuno¯uorescence assays revealed that p13 II , detected as a red signal, and MT-GFP-HA1, detected as a green signal, were expressed in a mutually exclusive manner in most of the cells ( Figure 5A , compare left and middle photographs). This observation was surprising, as cells transfected by calcium phosphate co-precipitation generally express all of the plasmids added in the transfection mixture. A minority of the transfected cells (about 10 ± 20%) coexpressing p13 II and MT-GFP-HA1 showed a clearly overlapping localization pattern that produced a yellow signal in the double exposures ( Figure 5A , right panel). While the cells expressing MT-GFP-HA1 alone contained typical ®lamentous mitochondria (e.g., see cell with green signal in Figure 5A , right panel), the p13 II positive and p13 II /MT-GFP-HA1-double positive cells contained mitochondria with markedly altered morphology (e.g., see cells with red signal and cell with yellow signal in Figure 5A , right panel). These results To better analyse these morphological ®ndings, similar transfections were examined at a higher magni®cation and, to further increase the resolution of the image, photographed using high contrast black-andwhite ®lm and printed as negative images. As shown in Figure 5B , p13 II -positive HLtat cells displayed a marked II , a mitochondrial protein coded by HTLV-I V Ciminale et al change in mitochondrial distribution from the normal interconnected network-like pattern ( Figure 5B , left panel) to more isolated clusters ( Figure 5B, right panel) . This disruption of normal mitochondrial architecture was even more evident in transfections carried out using the human rhabdomyosarcoma cell line RD4-TetOn, which normally exhibits a network of very thin mitochondria ( Figure 5C ).
The described eects on mitochondrial shape and distribution were also observed in transfections carried out using the smallest amount of p13 II -expressing plasmid that yielded a detectable signal (i.e., 300 ng plasmid/200 000 cells; data not shown). It is noteworthy that p13 II -GFP was also able to induce similar alterations in mitochondrial morphology, although this eect was not as prominent as that induced by unfused p13 II . Interestingly, mitochondria containing the MTS-GFP fusion protein also showed some degree of alteration in shape/distribution, suggesting that this eect might at least in part be related to the mechanism of mitochondrial targeting of the protein.
II expression on mitochondrial inner membrane potential and cytochrome c localization
The morphological alterations of p13 II -positive mitochondria were also compatible with the occurrence of swelling in situ, which may be a sign of disrupted mitochondrial inner membrane potential (Dc) and function. Thus, we investigated whether mitochondrial accumulation of p13 II was accompanied by changes in Dc using a qualitative assay based on accumulation of the cationic, lipophilic¯uorochrome tetramethylrhodamine (TMR). As TMR uptake depends on membrane integrity, we carried out these experiments using the p13 II -GFP expression plasmid, which allowed detection of the protein in living cells. As shown in Figure 6A , two types of responses were observed. Figure 6A , left panel), suggesting that these structural changes were not paralleled by a detectable loss of the mitochondrial Dc. A second subpopulation of the p13 II -GFPexpressing cells (indicated by closed arrows) displayed a selective loss of TMR accumulation ( Figure 6A , left panel), which was associated with relative clustering of mitochondria in the perinuclear area and with a partial redistribution of the p13 II -GFP signal from mitochondria to the cytosolic and nuclear compartments ( Figure  6A, middle panel) . Overall, the phenotypes observed in p13 II -GFP-expressing cells ranged from cells with slightly altered mitochondrial morphology/distribution and intact Dc to grossly altered mitochondrial morphology with nearly complete perinuclear clustering, prominent diusion of the p13 II -GFP signal in the cytosol and nucleus and complete disruption of Dc. The proportion of p13 II -expressing cells that displayed a loss of Dc varied somewhat from experiment to experiment and thus was dicult to quantify.
The maintenance of Dc observed in many p13 II -GFP-positive, morphologically altered mitochondria could result from regeneration of the protonic gradient following hydrolysis of glycolytic ATP by the F1F0 ATPase. However, results of control assays showed that addition of oligomycin, an F1F0 ATPase inhibitor, did not cause loss of mitochondrial TMR signal, suggesting that Dc was not maintained at the expense of glycolytic ATP and instead re¯ected normal inner membrane H + conductance and respiratory functions (data not shown). As expected, TMR was released from all mitochondria upon the addition of the protonophore FCCP (Carbonyl Cyanide p-Triuoromethoxyphenylhydrazone), which is known to collapse Dc (data not shown).
Disruption of Dc and mitochondrial clustering are early events occurring in cells committed to apoptotic cell death (Kroemer et al., 1997; De Vos et al., 1998) . Mitochondria play a key role in the apoptotic process through release of two intermembrane proteins, cytochrome c (Liu et al., 1996) and apoptosis-inducing factor (AIF) (Susin et al., 1996) . The cytosolic complex of cytochrome c and Apaf-1 activates the caspase proteolytic cascade, resulting in the execution of apoptotic cell death (Green, 1998) , while AIF directly activates a nuclear endonuclease (Susin et al., 1999) . Release of cytochrome c has been reported to occur both in depolarized as well as in high-Dc mitochondria (Yang et al., 1997) ; it was therefore important to test whether the mitochondrial changes induced by p13 II caused release of cytochrome c into the cytosol. To this end, the same p13 II -GFP-transfected cells examined with TMR described above were ®xed, permeabilized and analysed by immuno¯uorescence with anticytochrome c antibodies. Results of this analysis showed that p13 II -GFP-positive cells ( Figure 6A , middle panel), including those that exhibited a total loss of TMR signal ( Figure 6A , left panel, indicated by closed arrows), did not show detectable levels of cytochrome c release into the cytosol ( Figure 6A , right panel).
Additional dual labeling experiments were carried out to verify cytochrome c localization in cells expressing unfused p13 II . As shown in Figure 6B , p13 II -containing mitochondria (middle panel) also contained readily detectable levels of cytochrome c ( Figure 6B , left panel and double exposure at the right). Cytochrome c was not detected in the cytosol, thus con®rming the observations made using p13 II -GFP.
Discussion
HTLV-I produces several alternatively spliced mRNAs encoding proteins whose biological signi®cance is still obscure. The present study showed that one such orphan ' protein, p13 II , is speci®cally targeted to mitochondria. By mutational analysis, we de®ned a 10-amino acid amino-proximal region that is necessary and sucient for its mitochondrial targeting. Expression of p13 II results in a speci®c alteration of mitochondrial morphology consisting of a transition from typical string-like to rounded shapes accompanied by loss of Dc in many cells.
A novel mitochondrial targeting sequence
Although the amino acid sequence directing p13 II to mitochondria is predicted to form an a-helical structure typical of canonical MTS, this sequence appears to be distinct in three respects: (i) it is amino-proximal rather than amino-terminal; (ii) although it contains four arginines, they are not required for ecient mitochondrial targeting; (iii) it is not cleaved upon import.
Although not amino-terminal, the function of the p13 II MTS is apparently dependent on proximity to the amino-terminus, as a synthetic x-II ORF product initiating 55 amino acids upstream of the p13 II AUG shows a diuse localization pattern (mutant DNTof; D'Agostino et al., 1997). Import of mitochondrial proteins containing positively charged MTS is thought to occur through stepwise binding to acidic receptors of increasing anities (reviewed by Neupert, 1997) ; the observation that p13 II retains mitochondrial targeting when the four arginines within its MTS are replaced by glycines suggests that it might be imported via an alternate pathway that does not involve acidic receptors. The ®nding that the p13 II MTS is not cleaved upon import distinguishes it from typical MTS; other noteworthy exceptions include the matrix proteins chaperonin 10, rhodanese and 3-oxoacylCoA thiolase, and the inner membrane subunit VIIa of yeast cytochrome c oxidase (reviewed by Neupert, 1997) . The observation that most cells cotransfected with plasmids expressing MT-GFP-HA1 and p13 II express either protein in a mutually exclusive manner suggests that the two proteins might compete for interaction with components of an import pathway or for a position in their ®nal destination within the mitochondrion. Further analyses will be necessary to de®ne the import pathway and submitochondrial localization of p13 II .
Eects of p13 II on mitochondrial architecture and function
The alterations in mitochondrial shape and distribution induced by p13 II might re¯ect mitochondrial swelling and/or disruption of the interaction of mitochondria with the cytoskeleton and other organelles; either of these phenomena would be expected to have a strong impact on cellular processes.
Three-dimensional reconstructions of confocal microscopy images revealed that mitochondria form an interconnected network in contact with the endoplasmic reticulum that is of functional signi®cance in controlling cytosolic Ca 2+ homeostasis (Rizzuto et al., 1998) . The presence of clustered, rounded-up mitochondria in p13 II -expressing cells suggests that the protein might disrupt this network and in turn interfere with Ca 2+ signaling, a possibility that is currently being investigated in our laboratory.
Mitochondrial swelling is an osmotic process that results from solute and water diusion towards the matrix, and can occur by either electrophoretic or passive diusion mechanisms (Azzone and Azzi, 1965) . Swelling in response to energy-dependent uptake of monovalent cations, K + in particular, occurs with minimal loss of energy (`high energy' swelling). Because the inner membrane permeability remains low and the Dc can be regenerated by respiration, the swollen mitochondria retain high Dc and coupling. Swelling in response to passive diusion following an increase in membrane permeability occurs in fully deenergized mitochondria (`low energy' swelling); this is typically caused by opening of the permeability transition pore (PTP), an inner membrane high-conductance channel (reviewed by Bernardi, 1999 ) that plays a key role in the release of apoptogenic proteins (Kroemer et al., 1998) .
Interestingly, some, but not all, p13
II -expressing cells containing morphologically altered mitochondria show a decrease in Dc. Although we cannot at present explain this heterogeneity in Dc, it is tempting to speculate that p13 II expression might initially cause high-energy swelling (for example, via opening of K + channels), resulting in shape change with maintenance of Dc; further swelling would result in depolarization, voltage-dependent opening of the PTP (Bernardi, 1992) , and release of cytochrome c that would commit the cell to enter the apoptotic program. This is in part supported by the observation that p13 II -GFP-positive cells with loss of Dc also showed perinuclear clustering of mitochondria, a phenomenon that is also observed in cells treated with tumor necrosis factor, an inducer of apoptosis (De Vos et al., 1998) . However, the observation that p13 II does not trigger substantial release of cytochrome c into the cytosol suggests that the protein does not induce mitochondrial swelling severe enough to result in outer membrane rupture, at least in the somewhat restricted time frame of transient transfections. It is also possible that p13 II exerts dierent eects depending on the phase of the cell cycle, a variable that was not controlled in the present study. These working hypotheses will require thorough testing in systems allowing stable expression of p13 II and cell cycle synchronization.
Although the lack of detectable cytochrome c release would argue against a direct role for p13
II as an inducer of apoptotic cell death through a mitochondrial pathway, these results must be interpreted with caution, as the HLtat cell line appears to be resistant to apoptotic signals (unpublished observations). In this regard, it would be of interest to examine this cell line for the expression and function of the pro-and antiapoptotic proteins of the Bcl-2 family, as release of cytochrome c from mitochondria is inhibited by Bcl-2 (Kluck et al., 1997; Yang et al., 1997) . Preliminary experiments carried out using the human osteosarcoma cell line U2-OS have not revealed signi®cant dierences in cell cycle progression or cell survival between p13 II -expressing and mock-transfected control cells (data not shown).
General implications
The ®nding that a retroviral-encoded protein is targeted to the mitochondria and induces speci®c changes in the architecture of these organelles suggests possible novel mechanisms of virus-cell interactions that may play a role in HTLV-I replication and/or pathogenicity. Besides p13 II , to our knowledge, the BHRF1 protein of Epstein-Barr virus is the only other virus-encoded mitochondrial protein described thus far (Hickish et al., 1994) ; BHRF1 shows homology to Bcl-2 and protects cells against apoptosis (Henderson et al., 1993) . Studies of other viruses have delineated distinct mechanisms by which mitochondria might play important roles during viral infection. African swine fever virus has been shown to induce migration of mitochondria to perinuclear virus assembly sites, a phenomenon that appears to depend on the microtubular network. These mitochondria appear to have enhanced respiratory functions and thus could provide energy for viral morphogenesis (Rojo et al., 1998) ; stimulation of mitochondrial respiratory metabolism was also shown in adenovirus-infected cells (Tollefson et al., 1996) .
The fact that the p13 II coding region is conserved among HTLV-I isolates and that its mRNA has been detected in cells derived from HTLV-I-infected individuals (Koralnik et al., 1992) , along with the detection of serological reactivity against an x-II ORF product in TSP/HAM patients (Chen et al., 1997) , provide indirect evidence that p13 II might play an important role in HTLV-I biology, possibly in connection with the development of TSP/HAM. Further studies will be required to investigate the production of p13 II in the context of infection and its possible eect on the life cycle/pathogenetic potential of HTLV-I, particularly in T lymphocytes, the natural target of HTLV-1 infection.
Materials and methods
Cells and transfections
The present study was carried out using the HeLa-derived cell line HLtat, which constitutively expresses the HIV-1 Tat protein (Schwartz et al., 1990) , and RD4-TetOn, derived from the human rhabdomyosarcoma cell line RD4 by stable transfection of pTet-On (Clontech); these lines were utilized due to their high transfection eciency compared to the parent cell lines. Cells were grown in Dulbecco's Modi®ed Eagle's medium (4500 mg/ml glucose) supplemented with 10% fetal calf serum, and transfected by calcium-phosphate coprecipitation (Graham and van der Eb, 1973) . Plasmids used in transfections were puri®ed by anion exchange chromatography (Genomed). 
Plasmids and mutants
The p13 II expression plasmid pLs1-C contained exon 1 (nt 1 ± 119) and the 5' portion of exon C (i.e., nt 6875 ± 7223) of the infectious HTLV-I molecular clone CS-HTLV-I (Derse et al., 1995) , inserted into the HIV-1 LTR promoter-driven vector pLdKL3pA (Mermer et al., 1990) . As described before (Koralnik et al., 1993), p13 II expression plasmid pCMVp13 II -HA1 contained the p13 II ORF (derived from the HTLV-I-infected cell line LAF) modi®ed by tagging with the HA1 epitope of in¯uenza virus (YPYDVPDYASL), inserted into the CMV promoter-driven vector pHCMV-hspA . Although the p13 II sequence of CS-HTLV-I and LAF-HTLV-I diers at amino acids 28 (i.e., A in CS, T in LAF) and 68 (i.e., Q in CS, R in LAF), both variants exhibited mitochondrial targeting (e.g., compare Figures 2 and 5). p13 II -GFP fusion proteins were generated by attaching portions of the p13 II coding sequence derived from CS-HTLV-I to the 5' end of the Aequorea victoria green uorescent protein (GFP) open reading frame (Prasher et al., 1992 II (RVWRLCTRRL) fused to GFP; MTSDa-GFP was derived from MTS-GFP by substituting hydrophobic amino acids with polar and negatively charged residues, resulting in NGDRECTGRR (conserved residues underlined). All of the GFP hybrids contained an initiator methionine coded by an AUG codon supplied by a Kozak consensus sequence; this modi®cation of the coding sequence resulted in the insertion of a valine codon 5' to the p13 II sequence in fusion proteins p13 II -M2-GFP, p13 II -M4-GFP, MTS-GFP and MTS-Da-GFP. GFP hybrids were generated either by PCR or restriction enzyme digestion and insertion of double-stranded oligonucleotides coding for the foreign sequence, and were expressed in pLdKL3pA-derived plasmids. Mutations were introduced using a PCR-based sitedirected mutagenesis method (QuickChange, Stratagene). PCR ampli®cations were carried out using Vent DNA polymerase (New England Biolabs) in a Perkin Elmer GeneAmp 9600 thermal cycler. Products of in vitro mutagenesis were veri®ed by DNA sequencing (Thermosequenase cycle sequencing kit, Amersham). Restriction enzymes were purchased from New England Biolabs and Roche, and synthetic oligonucleotides were purchased from European Primer.
Indirect immuno¯uorescence
Twenty-four to 36 h after transfection, cells were either analysed in vivo for their constitutive¯uorescence (GFP fusion proteins and tetramethylrhodamine staining), or by indirect immuno¯uorescence after ®xing in formaldehyde (3.7%) and permeabilizing with Nonidet P40 (0.1%). p13 II was detected using a rabbit serum recognizing the carboxy terminus of the x-II ORF (rabbit anti-Tof; Ciminale et al., 1992) . Mitochondrial multienzyme complex III was detected using rabbit anti-complex III serum (a gift from R Bisson, University of Padova). Proteins modi®ed with the HA1 epitope were detected using a mouse anti-HA1 monoclonal antibody (BAbCO). Cytochrome c was detected using monoclonal antibody 6H2.B4 (PharMingen). Fluoresceinand Texas red-conjugated secondary antibodies were purchased from Sigma and Jackson Immunoresearch Laboratories, respectively. Epi¯uorescence analysis were carried out using Zeiss Axioplan and Olympus IX70 microscopes.
Tetramethylrhodamine (TMR) staining
To evaluate the proton gradient across the inner mitochondrial membrane (Dc), transfected cells were treated with 5 nM TMR (Sigma) for 30 min at 378C and then examined bȳ uorescence microscopy as living cultures. As TMR is known to be a substrate for the multidrug resistance (MDR) pump (Dietal et al., 1994) , TMR labeling reactions were carried out in the presence of 20 mg/ml verapamil (Sigma) to suppress MDR activity and allow for ecient and uniform TMR staining of the cells (Petronilli et al., 1998) . Speci®city of TMR staining for mitochondria with an intact Dc was veri®ed by cytosolic diusion of the signal upon treatment with 5 mM FCCP.
Production of p13
II in bacteria as a glutathione S transferase (GST) fusion protein
GST-p13
II was produced in bacterial strain BL21 from a plasmid derived from vector pGEX2T (Pharmacia) that contained the p13 II coding sequence linked in-frame to the 3' end of the GST gene. Isopropyl b-D-thiogalactopyranoside (IPTG)-treated bacteria were lysed in 50 mM Tris-HCl, pH 8.0, 25% sucrose, 1 mM EDTA, 0.5% Triton X-100, and 100 mg/ml lysozyme (Roche) and then clari®ed by centrifugation at 17,500 g and 48C for 10 min. GST-p13 II was puri®ed from the resulting supernatant by anity chromatography using glutathione-Sepharose (Pharmacia) and p13 II was separated from the GST moiety by proteolytic cleavage with bovine thrombin (Sigma), all as described elsewhere (Smith and Corcoran, 1994) .
